Literature DB >> 18664540

Notch signaling is involved in expression of thyrocyte differentiation markers and is down-regulated in thyroid tumors.

E Ferretti1, E Tosi, A Po, A Scipioni, R Morisi, M S Espinola, D Russo, C Durante, M Schlumberger, I Screpanti, S Filetti, A Gulino.   

Abstract

CONTEXT: Notch genes encode receptors for a signaling pathway that regulates cell growth and differentiation in various contexts, but the role of Notch signaling in thyroid follicular cells has never been fully published.
OBJECTIVE: The objective of the study was to characterize the expression of Notch pathway components in thyroid follicular cells and Notch signaling activities in normal and transformed thyrocytes. DESIGN/SETTING AND PATIENTS: Expression of Notch pathway components and key markers of thyrocyte differentiation was analyzed in murine and human thyroid tissues (normal and tumoral) by quantitative RT-PCR and immunohistochemistry. The effects of Notch overexpression in human thyroid cancer cells and FTRL-5 cells were explored with analysis of gene expression, proliferation assays, and experiments involving transfection of a luciferase reporter construct containing human NIS promoter regions.
RESULTS: Notch receptors are expressed during the development of murine thyrocytes, and their expression levels parallel those of thyroid differentiation markers. Notch signaling characterized also normal adult thyrocytes and is regulated by TSH. Notch pathway components are variably expressed in human normal thyroid tissue and thyroid tumors, but expression levels are clearly reduced in undifferentiated tumors. Overexpression of Notch-1 in thyroid cancer cells restores differentiation, reduces cell growth rates, and stimulates NIS expression via a direct action on the NIS promoter.
CONCLUSION: Notch signaling is involved in the determination of thyroid cell fate and is a direct regulator of thyroid-specific gene expression. Its deregulation may contribute to the loss of differentiation associated with thyroid tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18664540     DOI: 10.1210/jc.2008-0528

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

1.  Second-generation Notch1 activity-trap mouse line (N1IP::CreHI) provides a more comprehensive map of cells experiencing Notch1 activity.

Authors:  Zhenyi Liu; Eric Brunskill; Scott Boyle; Shuang Chen; Mustafa Turkoz; Yuxuan Guo; Rachel Grant; Raphael Kopan
Journal:  Development       Date:  2015-02-27       Impact factor: 6.868

2.  Expression and localization of the sodium/iodide symporter (NIS) in testicular cells.

Authors:  Diego Russo; Angela Scipioni; Cosimo Durante; Elisabetta Ferretti; Loredana Gandini; Valentina Maggisano; Donatella Paoli; Antonella Verrienti; Giuseppe Costante; Andrea Lenzi; Sebastiano Filetti
Journal:  Endocrine       Date:  2011-04-16       Impact factor: 3.633

Review 3.  Novel approaches in anaplastic thyroid cancer therapy.

Authors:  Kun-Tai Hsu; Xiao-Min Yu; Anjon W Audhya; Juan C Jaume; Ricardo V Lloyd; Shigeki Miyamoto; Tomas A Prolla; Herbert Chen
Journal:  Oncologist       Date:  2014-09-26

4.  Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo.

Authors:  Xiao-Min Yu; TramAnh Phan; Priyesh N Patel; Renata Jaskula-Sztul; Herbert Chen
Journal:  Cancer       Date:  2012-09-18       Impact factor: 6.860

Review 5.  Recent insights into the cell biology of thyroid angiofollicular units.

Authors:  Ides M Colin; Jean-François Denef; Benoit Lengelé; Marie-Christine Many; Anne-Catherine Gérard
Journal:  Endocr Rev       Date:  2013-01-24       Impact factor: 19.871

6.  Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer.

Authors:  Priyesh N Patel; Xiao-Min Yu; Renata Jaskula-Sztul; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2014-01-14       Impact factor: 5.344

7.  Notch pathway is activated by MAPK signaling and influences papillary thyroid cancer proliferation.

Authors:  Alex Shimura Yamashita; Murilo Vieira Geraldo; Cesar Seigi Fuziwara; Marco Aurélio Vamondes Kulcsar; Celso Ubirajara Moretto Friguglietti; Ricardo Borges da Costa; Gilson Soares Baia; Edna Teruko Kimura
Journal:  Transl Oncol       Date:  2013-04-01       Impact factor: 4.243

Review 8.  Modulation of sodium iodide symporter in thyroid cancer.

Authors:  Aparna Lakshmanan; Daniel Scarberry; Daniel H Shen; Sissy M Jhiang
Journal:  Horm Cancer       Date:  2014-09-19       Impact factor: 3.869

Review 9.  Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review.

Authors:  Heewa Shakib; Sadegh Rajabi; Mohammad Hossien Dehghan; Farideh Jalali Mashayekhi; Nahid Safari-Alighiarloo; Mehdi Hedayati
Journal:  Endocrine       Date:  2019-08-04       Impact factor: 3.633

10.  Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth.

Authors:  Xiao-Min Yu; Renata Jaskula-Sztul; Kamal Ahmed; April D Harrison; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Mol Cancer Ther       Date:  2013-04-17       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.